William Edward McKechnie, Director at Lexaria Bioscience Corp. (LEXX), bought 5,000 shares at $0.91 ($5K) on 2025-07-29, disclosed to the SEC on 2025-07-30.
Open-market purchase of $5k LEXX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |